This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
U.S. Dollar Hits 19-Month High: 5 Top Domestic Picks
by Nalak Das
Weaker-than-expected economic data from China and the European Union and concerns about emerging markets' ability to service their external debt have raised the possibility of global slowdown.
Can a Divided Congress Boost Healthcare Stocks? 4 Picks
by Zacks Equity Research
A divided Congress ensures Obamacare stays in place.
Moody's Downgrades Acadia's (ACHC) Outlook, Affirms Ratings
by Zacks Equity Research
Acadia Healthcare (ACHC) receives rating actions from Moody's. Outlook down to negative from stable.
Molina (MOH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Molina (MOH) closed at $140.01 in the latest trading session, marking a +1.12% move from the prior day.
Increased Earnings Estimates Seen for Molina Healthcare (MOH): Can It Move Higher?
by Zacks Equity Research
Molina Healthcare (MOH) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
HMO Industry Surges Almost 4 Times S&P 500: 4 Picks
by Sapna Bagaria
Health insurers gains on strong industry and operating conditions, the same should continue in 2019.
Molina (MOH) Up 10.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana to Gain from Share Buyback, Raise Membership Outlook
by Zacks Equity Research
Humana (HUM) announces accelerated share buyback and gears up for increased Medicare Advantage membership.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
6 Reasons Why You Should Add Anthem Stock to Your Portfolio
by Zacks Equity Research
Riding high on robust results, strong capital efficiency and buyouts; Anthem (ANTM) holds great prospects to reap returns for investors.
MEDNAX and Unit Unveil Incubator for Better Patient Results
by Zacks Equity Research
MEDNAX (MD) and its radiology arm launch MDR-AI Incubator to develop products for better patient care.
Here's Why Humana (HUM) Stock Looks Attractive Right Now
by Zacks Equity Research
Favorable changes across the industry and Humana's (HUM) strong operating profitability poise it for solid growth.
New Trends in Healthcare Push Stocks Higher: 5 Picks
by Zacks Equity Research
New healthcare trends backed by split party control of Congress are likely to boost industry stocks.
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
Why UnitedHealth (UNH) is an Attractive Stock to Own Now
by Zacks Equity Research
Medicaid expansion, upward revision in earnings guidance and inherent business strength make UnitedHealth (UNH) an attractive bet.
Humana, PIP Collaborate on Better HealthCare for MA Members
by Zacks Equity Research
Humana (HUM) enters into an agreement with Premier Independent Physicians to provide Medicare Advantage Members in Dallas-Fort Worth Metro with a better patient experience.
Surging Dollar to Hurt US Exports: 5 Top Domestic Picks
by Nalak Das
U.S. products are losing competitiveness in the international market due to strong dollar.
Zacks.com featured highlights include: ArcBest, Molina, Avis Budget, Cincinnati Bell and AMC
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, Molina, Avis Budget, Cincinnati Bell and AMC
Here's What Makes Molina Healthcare (MOH) an Attractive Bet
by Zacks Equity Research
Favorable changes across the industry and inside the company poise Molina Healthcare (MOH) for strong growth.
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.
5 Stocks to Watch Out For on Recent Broker Rating Upgrades
by Zacks Equity Research
Broker advice is sought by investors as they strive to build a portfolio for generating handsome returns.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
DXC Technology (DXC) Q2 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
DXC Technology's (DXC) fiscal Q2 earnings hurt by delay in ramp-up of a few large digital contracts. However, strength in digital business remains a tailwind.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing